UK Regulator Wants More Patient/Public Involvement In Decision-Making
Input Requested Into New Innovative Licensing Pathway
In launching its latest consultation, the MHRA says it wants to see much more focus on the role of the ‘patient and public voice’ in shaping the way it makes regulatory decisions.
You may also be interested in...
The UK MHRA has pushed back the timelines for delivering some of the objectives listed in its first five-year strategy on involving patients and public in regulatory decision-making.
The UK government has revealed a number of changes it is making to the health care system in response to a report that found serious lapses regarding the safety of patients who were using certain treatments.
Efforts to overhaul the EU pharmaceutical legislation have been given added impetus after the European Parliament called for action to boost innovation and medicines access, shore up manufacturing and supply chains, and examine the link between R&D spending and drug prices.